SCHEMBL578026

SCHEMBL578026

Cc1ccc(Br)c(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6604967 0.97 RAB9A (0.42)
Bicarbonate SCHEMBL3763150 0.89 RAB9A (0.43)
SCHEMBL4123340 0.78
SCHEMBL156190 0.78
SCHEMBL31452225 0.78
SCHEMBL30390034 0.78
SCHEMBL9355994 0.77 CCR1 (0.67)
SCHEMBL16792339 0.75 IDO1 (0.35)
SCHEMBL502824 0.74
SCHEMBL1347449 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174993-A Preparation method of 2, 6-dimethylpyridine-3-boric acid 郑州萃智医药科技有限公司 2021-01-05 CN claimed
CN-107056692-A A kind of synthetic method of the bromopyridine of 2,6 dimethyl 3 刘瑞海 2017-08-18 CN claimed
US-20260125367-A1 CANCER TREATMENTS TARGETING CANCER STEM CELLS REMEDY PLAN, INC. (US) 2026-05-07 US disclosed
US-20260107625-A1 LIGHT-EMITTING DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2026-04-16 US disclosed
US-20260026183-A1 Light-Emitting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-01-22 US disclosed
US-12522587-B2 Cancer treatments targeting cancer stem cells REMEDY PLAN, INC. (US) 2026-01-13 US disclosed
CN-120647959-B COF nano-sheet for enhancing flame retardant property of PVC (polyvinyl chloride) and PE (polyethylene) pipes and preparation method and application thereof 京华塑业有限公司 2025-12-12 CN disclosed
EP-3766875-B1 COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE, A DISPLAY DEVICE AND A LIGHTING DEVICE COMPRISING THE SAME NOVALED GMBH (DE) 2025-11-19 EP disclosed
US-20250318430-A1 Compound and an Organic Semiconducting Layer, an Organic Electronic Device, a Display Device and a Lighting Device Comprising the Same NOVALED GMBH (DE) 2025-10-09 US disclosed
CN-120647959-A COF nano-sheet for enhancing flame retardant property of PVC (polyvinyl chloride) and PE (polyethylene) pipes and preparation method and application thereof 京华塑业有限公司 2025-09-16 CN disclosed
US-20250282782-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS GENZYME CORP (US) 2025-09-11 US disclosed
EP-0313295-A2 Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases PFIZER INC. (US) 1989-04-26 EP disclosed
EP-0313296-A2 Substituted chromans and related compounds in the treatment of asthma PFIZER INC. (US) 1989-04-26 EP disclosed
CN-1032439-A A kind of preparation method of platelet-activating factor antagonist PFIZER LTD (GB) 1989-04-19 CN disclosed
EP-0310386-A2 4-Aryl-5-carbamoyl-1,4-dihydropyridines Pfizer Limited (GB) 1989-04-05 EP disclosed
US-4783467-A Tetrahydroimidazoquinazolinone inotropic agents PFIZER INC. (US) 1988-11-08 US disclosed
US-4710507-A Quinolone inotropic agents PFIZER INC. (US) 1987-12-01 US disclosed
EP-0225172-A1 Process for the preparation of 5-chloro and 5-bromo-2-hydroxynicotinicacids A.H. ROBINS COMPANY, INCORPORATED (US) 1987-06-10 EP disclosed
EP-0205280-A2 Tetrahydroimidazoquinazolinone cardiac stimulants Pfizer Limited (GB) 1986-12-17 EP disclosed
EP-0148623-A2 Quinolone inotropic agents Pfizer Limited (GB) 1985-07-17 EP disclosed